NobleOak Life (ASX:NOL) has provided an update on the potential impact of Victorian stamp duty reforms, following its April 3, 2025 announcement and disclosures in its FY25 financial accounts.
The Aurora 140-megawatt Battery Energy Storage System has secured a major regulatory milestone after the Australian Energy Market Operator and South Australian transmission operator ElectraNet accepted its proposed Generator Performance Standards under the National Electricity Rules
Vitasora Health (ASX:VHL) has completed its $11 million capital raise, following the full receipt of a $6.8 million cornerstone investment at a placement price of $0.03 per share.
Capstone Copper (ASX:CSC) has announced record consolidated copper production for 2025, meeting its annual guidance with 224,764 tonnes—an increase of 22% over 2024 and 37% over 2023.
IperionX (ASX:IPX) has received the final US$4.6 million of a previously awarded US$47.1 million from the US Department of War.
Lunnon Metals (ASX:LM8) has completed a feasibility study on its Lady Herial gold deposit, part of the Kambalda Gold & Nickel Project.
Evolution Energy Minerals (ASX:EV) has recommenced soil sampling at its Chikundo Copper Project, located within the company's highly prospective Chilalo tenure in southern Tanzania.
Australia welcomed 1.85 million international arrivals in November 2025, marking an 8.4% increase compared with the same month in 2024.
Forrestania Resources (ASX:FRS) has moved to strengthen its Coolgardie Hub in Western Australia by entering a binding heads of agreement to acquire rights, title, and interests in tenements from Christopher Alan De Courcy Ryder and Lloyd George Holdings (Gibraltar).
Qube Holdings (ASX:QUB) has confirmed that Macquarie Asset Management has met the conditions outlined in their November 2025 exclusivity agreement.
Sonic Healthcare's (ASX:SHL) new CEO, Jim Newcombe, is facing investor pressure to reconsider the company’s US operations as he steps into the shoes of long-serving predecessor Colin Goldschmidt.
Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX), a global leader in 3D-printed biomimetic and bioresorbable implants, has entered a multi-year exclusive agreement with Majeton to commercialise its dental, orthodontic, and maxillofacial products across China, Hong Kong, and Macau.
